Ulcerative Colitis
Conditions
Interventions
control group:TCM placebo + WM
intervention group:TCM + WM
Sponsors
The Second Affiliated Hospital of Guangzhou University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Cases that meet the clinical diagnosis and definitive diagnosis of Western diagnostic criteria; 2. Meets the criteria for ulcerative colitis in mild to moderate active periods; 3. Diagnostic criteria for spleen deficiency and dampness syndrome in line with expert consensus; 4. Signed informed consent, good compliance, and follow-up; 5. Outpatient or hospitalized patients aged 18 to 70 years; 6. Do not use drugs or other treatments that affect the evaluation of efficacy during treatment.
Exclusion criteria
Exclusion criteria: 1. Lactation, pregnant women, and patients intolerant to this drug; 2. Severe primary disease such as severe heart, lung, liver, kidney and hematopoietic system, mental patients; 3. Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease; 4. Persons with disabilities prescribed by law (dumb, sputum, blindness, mental disorder, physical disability, mental retardation).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UC disease activity index;TCM syndrome effect;Single symptom efficacy;Inflammatory bowel disease quality of life questionnaire;intestinal mucosal scores;erythrocyte sedimentation rate and C-reactin protein;Disease remission rate; | — |
Countries
China
Contacts
Public ContactHuang Shaogang
The Second Affiliated Hospital of Guangzhou University of TCM
Outcome results
None listed